Thomsen LM. Patient safety in relation to biosimilars – how can we act as a patient organisation? EULAR 2017, OP0328-PARE.
Lage versus hoge dosis GC plus rituximab bij ANCA-vasculitis: resultaten na 2 jaar
jan 2024
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE